Single-cell transcriptomics reveal a hyperacute cytokine and immune checkpoint axis after cardiac arrest in patients with poor neurological outcome

单细胞转录组学揭示了心脏骤停后神经功能预后不良患者中存在的超急性细胞因子和免疫检查点轴。

阅读:5
作者:Tomoyoshi Tamura ,Changde Cheng ,Wenan Chen ,Louis T Merriam ,Humra Athar ,Yaunghyun H Kim ,Reshmi Manandhar ,Muhammad Dawood Amir Sheikh ,Mayra Pinilla-Vera ,Jack Varon ,Peter C Hou ,Patrick R Lawler ,William M Oldham ,Raghu R Seethala ,Yohannes Tesfaigzi ,Rebecca M Baron ,Fumito Ichinose ,Katherine M Berg ,Erin A Bohula ,David A Morrow ,Xiang Chen ,Edy Y Kim

Abstract

Background: Most patients hospitalized after cardiac arrest (CA) die because of neurological injury. The systemic inflammatory response after CA is associated with neurological injury and mortality but remains poorly defined. Methods: We determine the innate immune network induced by clinical CA at single-cell resolution. Findings: Immune cell states diverge as early as 6 h post-CA between patients with good or poor neurological outcomes 30 days after CA. Nectin-2+ monocyte and Tim-3+ natural killer (NK) cell subpopulations are associated with poor outcomes, and interactome analysis highlights their crosstalk via cytokines and immune checkpoints. Ex vivo studies of peripheral blood cells from CA patients demonstrate that immune checkpoints are a compensatory mechanism against inflammation after CA. Interferon γ (IFNγ)/interleukin-10 (IL-10) induced Nectin-2 on monocytes; in a negative feedback loop, Nectin-2 suppresses IFNγ production by NK cells. Conclusions: The initial hours after CA may represent a window for therapeutic intervention in the resolution of inflammation via immune checkpoints. Funding: This work was supported by funding from the American Heart Association, Brigham and Women's Hospital Department of Medicine, the Evergreen Innovation Fund, and the National Institutes of Health.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。